NEO Neogenomics Inc.
Health Care, filed as NEOGENOMICS INC (COM NEW), Equity Among managers we track Quote on Google Finance, opens in a new tab
No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.
Insider trades
Open-market buys and sales by NEO's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $321K sold by 1 insider outside a trading plan
- $646K sold by 3 insiders under 10b5-1 plans
-
Greg D. Aunan Chief Accounting OfficerSale$321K 20,000 shares at $16.07 80% of stakeTraded Aug 4 Filed Aug 6
-
Lynn A. Tetrault DirectorPlanned sale$59K 5,307 shares at $11.10 5.8% of stakeTraded Jun 15 Filed Jun 17
-
Lynn A. Tetrault DirectorPlanned sale$60K 5,307 shares at $11.29 5.5% of stakeTraded Jun 9 Filed Jun 11
-
Warren Stone COOPlanned sale$277K 22,128 shares at $12.50 15% of stakeTraded Jan 20 Filed Jan 21
-
Alicia C. Olivo EVP, GC & Business DevelopmentPlanned sale$251K 20,916 shares at $12.00 40% of stakeTraded Nov 25, 2025 Filed Nov 28, 2025
-
Alicia C. Olivo EVP, GC & Business DevelopmentPlanned sale$49K 4,918 shares at $10.00 10% of stakeTraded Oct 16, 2025 Filed Oct 20, 2025
Also filed in the last 12 months, not counted as buying or selling: 26 option exercises and 22 share withholdings for taxes.
Congress
1 member of Congress traded NEO in the last three years: 2 buys and 0 sales. 2 members listed it in 2025 annual reports.
-
Gilbert Ray Cisneros, Jr.
Buy
$1K–$15K
Aug 7
filed Sep 10
-
Gilbert Ray Cisneros, Jr.
Buy
$1K–$15K
May 7, 2025
filed Jun 6, 2025
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 2.02,5.02,5.03,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K/A | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.03,3.02,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $596.81M | $596.02M | $376.29M |
| Total non-current assets | $1.08B | $1.04B | $0.984B |
| Total assets | $1.68B | $1.64B | $1.36B |
| Total current liabilities | $96.3M | $301.24M | $88.3M |
| Total non-current liabilities | $643.39M | $434.46M | $434.97M |
| Total equity | $941.54M | $902.34M | $836.56M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon